STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Update

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,300 shares, an increase of 35.3% from the February 28th total of 1,700 shares. Based on an average trading volume of 6,000 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.1% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Separately, Maxim Group assumed coverage on shares of STRATA Skin Sciences in a research report on Thursday, February 27th. They issued a “buy” rating and a $6.00 target price for the company.

STRATA Skin Sciences Trading Up 1.1 %

Shares of SSKN traded up $0.03 during mid-day trading on Tuesday, hitting $2.67. 201 shares of the company’s stock traded hands, compared to its average volume of 12,090. The business’s 50-day moving average price is $2.74 and its 200-day moving average price is $2.90. STRATA Skin Sciences has a 1 year low of $2.51 and a 1 year high of $5.90. The firm has a market capitalization of $11.14 million, a P/E ratio of -1.00 and a beta of 1.32. The company has a quick ratio of 0.94, a current ratio of 1.13 and a debt-to-equity ratio of 1.62.

STRATA Skin Sciences (NASDAQ:SSKN) last released its quarterly earnings results on Thursday, March 27th. The medical device company reported ($1.13) earnings per share for the quarter, missing the consensus estimate of ($0.40) by ($0.73). The firm had revenue of $33.56 million for the quarter, compared to the consensus estimate of $9.03 million. STRATA Skin Sciences had a negative net margin of 28.72% and a negative return on equity of 69.33%. As a group, sell-side analysts forecast that STRATA Skin Sciences will post -1.05 EPS for the current fiscal year.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.